Literature DB >> 29551131

Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Scott T Eblen1.   

Abstract

The extracellular-regulated kinases ERK1 and ERK2 are evolutionarily conserved, ubiquitous serine-threonine kinases that are involved in regulating cellular signaling in both normal and pathological conditions. Their expression is critical for development and their hyperactivation is a major factor in cancer development and progression. Since their discovery as one of the major signaling mediators activated by mitogens and Ras mutation, we have learned much about their regulation, including their activation, binding partners and substrates. In this review I will discuss some of what has been discovered about the members of the Ras to ERK pathway, including regulation of their activation by growth factors and cell adhesion pathways. Looking downstream of ERK activation I will also highlight some of the many ERK substrates that have been discovered, including those involved in feedback regulation, cell migration and cell cycle progression through the control of transcription, pre-mRNA splicing and protein synthesis.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adhesion; ERK; Feedback; MEK; Proliferation; RAS; Raf; Signaling; Substrates

Mesh:

Substances:

Year:  2018        PMID: 29551131      PMCID: PMC6007982          DOI: 10.1016/bs.acr.2018.02.004

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  214 in total

Review 1.  Ras oncogenes and their downstream targets.

Authors:  Krishnaraj Rajalingam; Ralf Schreck; Ulf R Rapp; Stefan Albert
Journal:  Biochim Biophys Acta       Date:  2007-01-28

2.  Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.

Authors:  Qun Pan; Ofer Shai; Leo J Lee; Brendan J Frey; Benjamin J Blencowe
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

3.  Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase.

Authors:  M Fukuda; Y Gotoh; E Nishida
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

Review 4.  Ovarian carcinogenesis and the biology of ovarian surface epithelium.

Authors:  N Auersperg; S L Maines-Bandiera; H G Dyck
Journal:  J Cell Physiol       Date:  1997-11       Impact factor: 6.384

Review 5.  Regulation of translation initiation by FRAP/mTOR.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

6.  Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice.

Authors:  G Pagès; S Guérin; D Grall; F Bonino; A Smith; F Anjuere; P Auberger; J Pouysségur
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

7.  Integration of MAP kinase signal transduction pathways at the serum response element.

Authors:  A J Whitmarsh; P Shore; A D Sharrocks; R J Davis
Journal:  Science       Date:  1995-07-21       Impact factor: 47.728

8.  Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry.

Authors:  Thomas Lee; Andrew N Hoofnagle; Yukihito Kabuyama; James Stroud; Xiaoshan Min; Elizabeth J Goldsmith; Lin Chen; Katheryn A Resing; Natalie G Ahn
Journal:  Mol Cell       Date:  2004-04-09       Impact factor: 17.970

9.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

Authors:  J Cheng; T Zhou; C Liu; J P Shapiro; M J Brauer; M C Kiefer; P J Barr; J D Mountz
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

10.  A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function.

Authors:  A D Catling; H J Schaeffer; C W Reuter; G R Reddy; M J Weber
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

View more
  49 in total

1.  Extracellular signal-regulated kinase 1/2 regulates NAD metabolism during acute kidney injury through microRNA-34a-mediated NAMPT expression.

Authors:  Justin B Collier; Rick G Schnellmann
Journal:  Cell Mol Life Sci       Date:  2019-12-23       Impact factor: 9.261

Review 2.  Molecular regulation of human skeletal muscle protein synthesis in response to exercise and nutrients: a compass for overcoming age-related anabolic resistance.

Authors:  Nathan Hodson; Daniel W D West; Andrew Philp; Nicholas A Burd; Daniel R Moore
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

Review 3.  Targeting ERK beyond the boundaries of the kinase active site in melanoma.

Authors:  Rachel M Sammons; Ranajeet Ghose; Kenneth Y Tsai; Kevin N Dalby
Journal:  Mol Carcinog       Date:  2019-06-12       Impact factor: 4.784

4.  A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.

Authors:  Rachel M Sammons; Nicole A Perry; Yangmei Li; Eun Jeong Cho; Andrea Piserchio; Diana P Zamora-Olivares; Ranajeet Ghose; Tamer S Kaoud; Ginamarie Debevec; Chandra Bartholomeusz; Vsevolod V Gurevich; Tina M Iverson; Marc Giulianotti; Richard A Houghten; Kevin N Dalby
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

5.  Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors.

Authors:  Yuyu He; Jie Li; Tomoyuki Koga; Jun Ma; Sanjay Dhawan; Yuta Suzuki; Frank Furnari; Varun V Prabhu; Joshua E Allen; Clark C Chen
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

6.  Effects of cigarette smoke extract on bronchial epithelial cells stimulated with Cryptococcus neoformans.

Authors:  Aline Beatriz Mahler Pereira; Jhony Robison Oliveira; Ana Leticia Julio Souza; Leonardo Andrade-Silva; Marcos Vinicius Silva; Paulo Roberto Silva; Mario Leon Silva-Vergara; Alexandre Paula Rogerio
Journal:  Med Microbiol Immunol       Date:  2021-07-06       Impact factor: 3.402

7.  Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.

Authors:  Zeyu Xing; Menglu Zhang; Xin Wang; Jiaqi Liu; Gang Liu; Kexin Feng; Xiang Wang
Journal:  J Mol Histol       Date:  2021-05-19       Impact factor: 2.611

8.  Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders.

Authors:  Jianping Hu; Jieli Wei; Hyerin Yim; Li Wang; Ling Xie; Margaret S Jin; Md Kabir; Lihuai Qin; Xian Chen; Jing Liu; Jian Jin
Journal:  J Med Chem       Date:  2020-12-07       Impact factor: 7.446

9.  DUSP7 regulates the activity of ERK2 to promote proper chromosome alignment during cell division.

Authors:  Xiao Guo; Ivan Ramirez; Yenni A Garcia; Erick F Velasquez; Ankur A Gholkar; Whitaker Cohn; Julian P Whitelegge; Bobby Tofig; Robert Damoiseaux; Jorge Z Torres
Journal:  J Biol Chem       Date:  2021-04-15       Impact factor: 5.157

10.  Immunoblot Validation of Phospho-Specific Antibodies Using Lung Cancer Cell Lines.

Authors:  Wilfredo M Pedreira-García; Jaileene Pérez-Morales; Camille Chardón-Colón; Jennifer Cabán-Rivera; Pedro G Santiago-Cardona
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.